<DOC>
	<DOCNO>NCT00233818</DOCNO>
	<brief_summary>The objective study assess performance safety formulation antiproliferative agent , sirolimus coat modified Bx VELOCITY Balloon-Expandable Stent mount Raptor Over The Wire ( OTW ) Stent Delivery System ( SDS ) patient de novo coronary artery lesion .</brief_summary>
	<brief_title>FIM-NL - First-in-Man Study ( Netherlands Part ) With Sirolimus Coated Modified BX Velocity Stent</brief_title>
	<detailed_description>This single center , non-randomized study . Patients meet eligibility criterion treat sirolimus coat modify Bx VELOCITY Balloon-Expandable Stent mount Raptor OTW SDS . Patients follow five year post-procedure , patient repeat angiography 6 month , 18 month , 48 month .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Diagnosis angina pectoris define Canadian Cardiovascular Society Classification ( CCS ) positive ischemia study ; 2 . Single de novo lesion require treatment major native coronary artery ; 3 . Target lesion &lt; =18mm length ( visual estimate ) ; 4 . Target lesion &gt; =3.0mm &lt; =3.5mm diameter ( visual estimate ) ; 5 . Target lesion stenosis &gt; 50 % &lt; 100 % ( visual estimate ) ; 1 . A Qwave nonQwave myocardial infarction within precede 72 hour unless CK CKMB enzymes back normal ; 2 . Unprotected leave main coronary disease &gt; =50 % stenosis ; 3 . Have ostial target lesion ; 4 . Angiographic evidence thrombus within target lesion ; 5 . Calcified lesion successfully predilated ; 6 . Ejection fraction &lt; =30 % ; 7 . Target lesion involve bifurcation ( either stenosis main vessel major branch stenosis major branch ) ; 8 . Totally occluded vessel ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>